You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 678 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-03

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
678 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-03
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2024

AbstractFullPdf
Nov 2022367036
Dec 2022184038
Jan 202363010
Feb 2023116020
Mar 2023120024
Apr 202384016
May 20236807
Jun 20236004
Jul 202378011
Aug 20239204
Sep 20235005
Oct 20236804
Nov 20235405
Dec 20237204
Jan 20242402
Feb 20244804
Mar 20245804
Apr 20246605
May 202412606
Jun 202474014
Jul 20248807
Aug 202458011
Sep 20249807
Oct 202492010
Nov 202411407
Total23220265